Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.
暂无分享，去创建一个
P. Neven | M. Piccart | G. Hortobagyi | J. Baselga | H. Rugo | M. Gnant | M. Campone | S. Noguchi | K. Pritchard | T. Taran | L. Provencher | Yoshinori Ito | I. Deleu | F. Lebrun | H. Burris | C. Wu | M. Shtivelband | Alejandra T. Perez | Jenna Fan | W. Feng